These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
4. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy]. Raby C Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756 [No Abstract] [Full Text] [Related]
5. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
6. The prevention of thrombosis. Bove LG J Maine Med Assoc; 1974 Oct; 65(10):233-5. PubMed ID: 4610070 [No Abstract] [Full Text] [Related]
7. Blood and neoplastic diseases. Thrombosis: treatment and prophylaxis. Browse NL Br Med J; 1974 Oct; 4(5936):96-9. PubMed ID: 4412220 [No Abstract] [Full Text] [Related]
8. [Current trends in anticoagulant and thrombolytic therapy of thrombosis]. Gavrilov OK; Rachinskaia NA; Kaveshnikova BF Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864 [No Abstract] [Full Text] [Related]
9. [Studies on the prothrombin complex, II. Behavior of prothrombin, factor VII, IX and X during column chromatography on anion exchangesRS]. Voss D Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1172-8. PubMed ID: 5588277 [No Abstract] [Full Text] [Related]
10. A true hypercoagulability state in patients on chronic hemodialysis. Erickson RV; Williman M; Pendras JP Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704 [No Abstract] [Full Text] [Related]
11. Management of thrombotic diseases. Douglas AS Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057 [No Abstract] [Full Text] [Related]
12. Gel filtration properties of factors II, VII, IX, IX a , and X. Osterud B; Schiffman S Thromb Diath Haemorrh; 1972 Oct; 28(2):317-24. PubMed ID: 4629507 [No Abstract] [Full Text] [Related]
13. [Indications for and hazards of anticoagulant therapy]. Straub PW Schweiz Med Wochenschr; 1970 Apr; 100(16):686-91. PubMed ID: 4258885 [No Abstract] [Full Text] [Related]
14. The effect of some antithrombotic drugs on experimental arterial thrombosis. Hladovec J Cor Vasa; 1975; 17(1):66-74. PubMed ID: 1149460 [TBL] [Abstract][Full Text] [Related]
16. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
17. Recognizing and reacting to recurrent pulmonary embolism. Genton E Geriatrics; 1973 Mar; 28(3):84-8. PubMed ID: 4691608 [No Abstract] [Full Text] [Related]
19. Toxicity of factor IX concentrates in mice. Magner A; Aronson D Dev Biol Stand; 1979; 44():185-8. PubMed ID: 544292 [TBL] [Abstract][Full Text] [Related]